Transfer Learning for Early Prediction of Adverse Drug Reactions: Docetaxel and Alopecia in Breast Cancer as a Case Study

被引：1

作者：

Dimitsaki, Stella ^{[1
,2
]}

Natsiavas, Pantelis ^{[2
]}

Jaulent, Marie-Christine ^{[1
]}

机构：

[1] Univ Paris 13, Sorbonne Univ, INSERM, LIMICS, F-75006 Paris, France

[2] Ctr Res & Dev Hellas, Inst Appl Biosci, Thessaloniki, Greece

来源：

CARING IS SHARING-EXPLOITING THE VALUE IN DATA FOR HEALTH AND INNOVATION-PROCEEDINGS OF MIE 2023 | 2023年 / 302卷

关键词：

Breast cancer; docetaxel; adverse drug reaction; alopecia; transfer learning;

D O I：

10.3233/SHTI230158

中图分类号：

TP39 [计算机的应用];

学科分类号：

081203 ; 0835 ;

摘要：

Transfer Learning (TL) is an approach which has not yet been widely investigated in healthcare, mostly applied in image data. This study outlines a TL pipeline leveraging Individual Case Safety reports (ICSRs) and Electronic Health Records (EHR), applied for the early detection Adverse Drug Reactions (ADR), evaluated using of alopecia and docetaxel on breast cancer patients as use case.

引用

页码：396 / 397

页数：2

共 50 条

[41] Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients
Siew-Kee Low
Kazuma Kiyotani
Taisei Mushiroda
Yataro Daigo
Yusuke Nakamura
Hitoshi Zembutsu
Journal of Human Genetics, 2009, 54 : 564 - 571
[42] Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study
Yang, Jing
Sun, Ying-zi
Li, Qun-fang
Fu, Zheng
Guan, Yu-yao
Song, Chao
Zheng, Lei
BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
[43] Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients
Low, Siew-Kee
Kiyotani, Kazuma
Mushiroda, Taisei
Daigo, Yataro
Nakamura, Yusuke
Zembutsu, Hitoshi
JOURNAL OF HUMAN GENETICS, 2009, 54 (10) : 564 - 571
[44] Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case–control study
Jing Yang
Ying-zi Sun
Qun-fang Li
Zheng Fu
Yu-yao Guan
Chao Song
Lei Zheng
BMC Pharmacology and Toxicology, 24
[45] Study on prediction of early adverse events by CapeOX therapy in patients with colorectal cancer
Kumihashi, Yuki
Kasai, Yohei
Akagawa, Takuya
Yuasa, Yasuhiro
Ishikura, Hisashi
Sato, Youichi
JOURNAL OF MEDICAL INVESTIGATION, 2024, 71 (1-2): : 141 - 147
[46] Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
Eckhoff, Lise
Feddersen, Soren
Knoop, Ann S.
Ewertz, Marianne
Bergmann, Troels K.
ACTA ONCOLOGICA, 2015, 54 (04) : 530 - 537
[47] THERAPEUTIC DRUG MONITORING OF DOCETAXEL: A CASE REPORT OF ADMINISTRATION OF DOCETAXEL FOR BREAST CANCER PATIENT RECEIVING RIFAMPICIN AND CLARITHROMYCIN TREATMENT FOR NTM.
Yashima, H.
Araki, T.
Ishikawa, Y.
Oshima, S.
Nagano, D.
Obayashi, K.
Horiguchi, J.
Yamamoto, K.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S53 - S53
[48] Impact of Hyperparameter Optimization to Enhance Machine Learning Performance: A Case Study on Breast Cancer Recurrence Prediction
Gonzalez-Castro, Lorena
Chavez, Marcela
Duflot, Patrick
Bleret, Valerie
Del Fiol, Guilherme
Lopez-Nores, Martin
APPLIED SCIENCES-BASEL, 2024, 14 (13):
[49] Adverse drug reactions related to cytotoxic drugs: a pharmacovigilance study in a comprehensive cancer institute
Couffignal, AL
Lapeyre-Mestre, M
Bonhomme, C
Bugat, R
Montastruc, JL
THERAPIE, 2000, 55 (05): : 635 - 641
[50] Adverse drug reactions associated with chemotherapeutic agents used in breast cancer: Analysis of patients' online forums
Assi, Sulaf
Torrington, Ebony
Cheema, Ejaz
Hamid, Abdullah Al
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (01) : 108 - 118

← 1 2 3 4 5 →